Mackenzie Financial’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,101
Closed -$270K 1750
2025
Q4
$270K Sell
9,101
-441
-5% -$14.4K ﹤0.01% 1421
2025
Q3
$345K Sell
9,542
-6,613
-41% -$218K ﹤0.01% 1362
2025
Q2
$581K Buy
16,155
+568
+4% +$21.1K ﹤0.01% 1178
2025
Q1
$615K Buy
15,587
+6,699
+75% +$225K ﹤0.01% 1132
2024
Q4
$268K Sell
8,888
-7,609
-46% -$218K ﹤0.01% 1432
2024
Q3
$386K Buy
16,497
+5,715
+53% +$125K ﹤0.01% 1090
2024
Q2
$192K Hold
10,782
﹤0.01% 1349
2024
Q1
$164K Buy
+10,782
New +$172K ﹤0.01% 1372
2023
Q3
Sell
-18,788
Closed -$427K 1593
2023
Q2
$427K Buy
18,788
+6,053
+48% +$156K ﹤0.01% 1065
2023
Q1
$192K Buy
+12,735
New +$193K ﹤0.01% 1353
2021
Q4
Sell
-7,487
Closed -$249K 1498
2021
Q3
$249K Buy
+7,487
New +$232K ﹤0.01% 1215
2020
Q4
Sell
-31,940
Closed -$855K 1090
2020
Q3
$855K Buy
+31,940
New +$735K ﹤0.01% 696

Other funds holding TGTX